Diabetes Dialogue: BELIEVE, GLP-1/GIP Agonists, and CATALYST-2 Results at ADA 2025
Isaacs and Bellini discuss 3 more of the most impactful trials presented at the 85th annual American Diabetes Association conference in part 2 of this 2-part recap.
Related Articles
HCPLive Clinical Forum Events
Sign up for upcoming Clinical Forum events for Oncologists. Available virtually or in-person | HCPLive
Skin of Color Savvy: News Update—Consulting with Physicians Outside of Dermatology
This July 15, 2025 SOCS News Update highlights Regine Mathieu, MD’s experiences and views on collaboration opportunities.
FDA Approves Finerenone (Kerendia) for Heart Failure with Ejection Fraction of 40% or More
Finerenone gains FDA approval for heart failure treatment, offering new hope for patients with reduced ejection fraction and improving care options.
Liver Lineup: Progress, Policy, and Barriers in Hepatitis C Elimination
Hosts Kimberly Brown and Nancy Reau discuss policy, clinical, and structural milestones enabling HCV elimination efforts and critical gaps impeding progress.
Skin of Color Savvy: News Update—Consulting with Physicians Outside of Dermatology
This July 15, 2025 SOCS News Update highlights Regine Mathieu, MD’s experiences and views on collaboration opportunities.
Liver Lineup: Progress, Policy, and Barriers in Hepatitis C Elimination
Hosts Kimberly Brown and Nancy Reau discuss policy, clinical, and structural milestones enabling HCV elimination efforts and critical gaps impeding progress.
Skin of Color Savvy: News Update—Consulting with Physicians Outside of Dermatology
This July 15, 2025 SOCS News Update highlights Regine Mathieu, MD’s experiences and views on collaboration opportunities.
Neffy Effectively Treats Anaphylaxis in Pediatric Phase 3 Open-Label Trial
Neffy showed fast symptom resolution in children experiencing moderate anaphylaxis following oral food challenges, offering a needle-free alternative to epinephrine injection.
Neffy Effectively Treats Anaphylaxis in Pediatric Phase 3 Open-Label Trial
Neffy showed fast symptom resolution in children experiencing moderate anaphylaxis following oral food challenges, offering a needle-free alternative to epinephrine injection.
Events
HCPLive is a clinical news and information portal, offering physicians specialty and disease-specific resources, conference coverage, and interviews.